目的提高肝门部胆管癌的诊断水平。
Objective To improve diagnosis of hilar cholangiocarcinoma (HCCA).
目的提高肝门部胆管癌的诊断水平。
Objective To improve the levels of diagnosing hilar cholangiocarcinoma.
目的建立人肝门部胆管癌裸鼠瘤株模型。
Objective To establish a xenografted model of human hilar cholangiocarcinoma in nude mice.
目的介绍肝门部胆管癌的治疗进展动态。
Objective To introduce the development of therapy of hilar cholangiocarcinoma.
目的提高肝门部胆管癌手术治疗的效果。
Objectives To improve effect of the resection of hilar cholangiocarcinoma.
目的：探讨肝门部胆管癌有效的治疗方法。
Objective:To analyze the effective therapeutic method of hepatic portal cholangiocarcinoma.
方法将人肝门部胆管癌标本进行细胞培养，传代。
Methods The fresh human hilar cholangiocarcinoma specimen was cultured.
结果建立了肝门部胆管癌术后生存危险状态函数。
Results We have established mathematic function to evaluate postoperative survival risk state of hilar cholangiocarcinoma.
目的评价超声对肝门部胆管癌术前分期诊断价值。
Purpose To evaluate staging of hilar cholangiocarcinoma by ultrasound.
方法回顾性分析36例肝门部胆管癌患者的诊断情况。
MethodsThe clinical data on 36 patients with hilar cholangiocarcinoma were analyzed retrospectively.
目的：探讨术前减黄对肝门部胆管癌手术切除病人的影响。
Objective: To investigate the effect of preoperative biliary drainage (PTBD) on hilar cholangiocarcinoma in patients underwent resection operation.
目的总结肝门部胆管癌扩大根治术中肝动脉重建的临床经验。
Objective To sum up the clinical experience of hepatic artery reconstruction during radical surgery for treatment of hilar cholangiocarcinoma.
目的探讨肝门部胆管癌术前改良T分期系统的临床应用价值。
Objective To discuss the applicable clinic value of proposed T-staging for hilar cholangiocarcinoma.
目的：探讨影响肝门部胆管癌术后严重并发症发生的危险因素。
Objective: to investigate the risk factors which influenced the serious postoperative complication of hilar cholangiocarcinoma.
目的探讨晚期肝门部胆管癌患者经皮经肝门静脉栓塞术的护理。
Objective: Researching the effect of applying selective portal vein embolization (SPVE) in the primary hepatic carcinoma patients.
目的：探讨影响可手术切除的肝门部胆管癌患者预后的相关因素。
Objective: to explore the related factors that can influence the prognosis of patients with resectable hilar cholangiocarcinoma.
目的探讨单通道双支架植入技术治疗肝门部胆管癌的可行性和临床应用价值。
Objective To evaluate the feasibility and clinical application of two stents insertion via single tract for treatment of hepatic hilar cholangiocarcinoma.
说明肝、胰头、十二指肠联合切除并肝移植治疗肝门部胆管癌是安全可行的。
These suggest that simultaneous pancreaticoduodenectomy and liver transplantation as a treatment of hilar cholangiocarcinoma are safe and feasible.
结论肝门部胆管癌早期诊断困难，胆道镜联合超内镜可提高诊断率及手术成功率。
Conclusion Its still difficult to make early diagnosis of hilar cholangiocarcinoma. The rate of diagnosis in hilar cholangioca…
目的总结作者应用肝部分切除联合肝十二指肠骨髂化治疗肝门部胆管癌的临床经验。
Objective to summarize the surgical experience of partial hepatectomy with skeletonization of the hepatoduodenal ligament in the treatment of hilar cholangiocarcinoma.
目前手术切除仍是根治肝门部胆管癌的唯一方法，但是手术切除率及切净率均较低。
The primary curative modality for hilar cholangiocarcinoma is surgery. Some reports suggest that radical resection may provide the best survival rate for patients with hilar cholangiocarcinoma.
结论MRI和MRCP联合应用有助于肝门部胆管癌的诊断、分型及手术可切除性的评估。
Conclusion MRCP combined with MRI is very useful for diagnosis and classification of the hepatic hilar cholangiocarcinoma and assessment of tumor respectability.
目的：评价肝、胰头、十二指肠联合切除并肝移植治疗晚期肝门部胆管癌的安全性和可行性。
OBJECTIVE:To evaluate the safety and feasibility of simultaneous pancreaticoduodenectomy and liver transplantation for the end-stage hilar cholangiocarcinoma.
随着肝门部胆管癌手术技术方法的改善，放射治疗设备更新及技术方法的提高，放射治疗在肝门部胆管癌治疗中的应用亦增多。
With improvement of technology in surgery for cholangiocarcinoma, and renewing radiation equipment, radiotherapy for the treatment of hilar cholangiocarcinoma has been increased.
方法回顾分析22例经手术和病理证实的肝门部胆管癌患者的MRI及MRCP表现，以了解其影像特征和肿瘤的组织病理学特点。
Methods MRI and MRCP imaging as well as histopathologic features of 22 patients with hilar cholangiocarcinoma with surgical and pathological proofs were analyzed and studied retrospectively.
目的研究在肝门部胆管癌(H CCA)中雌激素受体(ER)表达水平和微血管密度(MVD)的改变，探讨它们在HCCA中可能发挥的作用。
Objective to study the expression of Estrogen Receptor (ER) and the change in microvessel density (MVD) in Hilar Cholangiocarcinoma (HCCA) and their significance.
目的研究在肝门部胆管癌(H CCA)中雌激素受体(ER)表达水平和微血管密度(MVD)的改变，探讨它们在HCCA中可能发挥的作用。
Objective to study the expression of Estrogen Receptor (ER) and the change in microvessel density (MVD) in Hilar Cholangiocarcinoma (HCCA) and their significance.
应用推荐